4F-MDMB-BINACA - Versionsgeschichte

PatrickI60 am 1. Juli 2026 um 08:30 Uhr

2026-07-01T08:30:09Z

SalinaHedin am 29. Juni 2026 um 14:10 Uhr

2026-06-29T14:10:07Z

FlorenceHardey2 am 18. Juni 2026 um 07:22 Uhr

2026-06-18T07:22:36Z

KarryTrethowan am 29. Mai 2026 um 02:00 Uhr

2026-05-29T02:00:37Z

FernSides2: Die Seite wurde neu angelegt: „Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) contro…“

2026-05-28T07:18:21Z

Die Seite wurde neu angelegt: „Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) contro…“

Neue Seite

Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may JWH-210 powder be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens. About Powder JWH-2 Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients." 🌟🌟🌟🌟🌟 You can buy jwh-210 online in quantities of [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality and discreet shipping. In some areas, it is classified as a controlled substance, while in others, it may be legal for research or incense use. The legal status of jwh-210 varies by country and region. Key Features and Specifications to Evaluate Higher prices often reflect rigorous quality control rather than markup alone. This compound is appropriate only for authorized professionals conducting lawful research or analysis. For legitimate applications, only fully characterized, independently tested JWH-210 JWH-210 powder should be considered. How to Choose Powder JWH-210 When learning how to choose powder JWH-210, the most critical factor is verifying high chemical purity (≥98%) from a reputable supplier with independent lab testing. We also demonstrated that JWH-210 administration resulted in the decrease of expression levels of T-cell activator including Cd3e, Cd3g, Cd74p31, and Cd74p41, while JWH-030 increased Cd3g levels. JWH-210 (10 mg/kg, 3 days, i.p.) is more likely to have cytotoxicity and reduce lymphoid organ weight than JWH-030 of ICR mice in vivo. Users are expected to handle the compound in accordance with all applicable regulations and safety guidelines within their jurisdiction. It is important to note that JWH-210 Chemical Powder is intended strictly for research and laboratory use only. Its reputation for purity and stability has contributed to its widespread use in controlled environments where precision is paramoun Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). JWH-210 powder Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin 4. Drugs In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Michael B Gatch Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the JWH-210 powder highest dose tested (0.5 mg/kg). Figure 1. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic

← Nächstältere Version		Version vom 1. Juli 2026, 08:30 Uhr
Zeile 1:		Zeile 1:
−	~~As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally~~, ~~clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests~~. ~~He confirmed that he had been vaping an electronic cigarette~~ (e-~~cigarette~~) ~~earlier~~ that ~~day just before~~ the ~~onset~~ of ~~his symptoms~~. ~~Metabolic acidosis (1~~/~~3, 0~~/~~7) and respiratory acidosis (1~~/~~3, 0~~/~~7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB~~-~~BUTINACA was the only substance detected~~, ~~while in seven other substances of misuse were also detected including other SCRA~~, ~~opioids~~, ~~benzodiazepines cocaine~~ and ~~pregabali~~<br><br>~~AMB~~-~~FUBINACA has been implicated~~ in ~~severe adverse effects in recreational users (Adams et al~~.~~, 2017; Hamilton et al~~., ~~2017), which suggests that the range between behaviorally active~~ and ~~toxic doses~~ of ~~AMB~~-~~FUBINACA is narro~~<br><br>~~<br>In~~ the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-~~maze test for learning/memory evaluation~~. ~~Known for its stability~~ and ~~consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-~~based ~~analytical studies. In this study, histopathological evaluation was performed to confirm~~ the ~~possibility~~ of ~~neurotoxicity of the tested substances by hematoxylin~~ and ~~eosin staining method~~ from ~~collected brain samples. In~~ the ~~present study, we evaluated the neurotoxicity~~ of ~~two synthetic cannabinoids (JWH~~-~~081~~ and ~~JWH-210) through observation~~ of ~~various behavioral changes~~ and ~~analysis~~ of ~~histopathological changes using experimental mice with various doses (0~~.1, 1, ~~5 mg/kg). Selecting powder JWH-210 demands careful evaluation~~ of ~~purity, legality, and supplier credibility~~. ~~Prices for research~~-~~grade JWH~~-~~210 vary significantly based~~ on ~~quantity, purity, and vendor complianc<br><br>Moreover, genetic makeup, physiological conditions~~ (~~age, gender and ethnicity~~)~~, environmental influences~~ (~~diet~~) and ~~pathological factors~~ (~~liver diseases~~, ~~diabetes~~, ~~and obesity~~) ~~would further complicate the metabolism of drug<br>~~<br><br>~~Tremors were observed~~ in ~~mice 30 minutes following 1 mg~~/~~kg AMB~~-~~FUBINACA in the present study~~. ~~Pretreatment times~~ and ~~dose ranges~~ for ~~the drug discrimination assay were selected based on the time~~ of ~~peak depression in the locomotor activity assay in mice. Average potency~~ of ~~the discriminative stimulus effects of early compounds was~~ 0.~~81±0~~.~~17 mg~~/~~kg (Gatch et al., 2014), whereas~~ the ~~potency~~ of ~~a recent set was 0~~.~~09±0~~.~~03 mg~~/~~kg (Gatch et al~~.~~, 2018),~~ and ~~the potency~~ of the ~~current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have~~ a ~~greater abuse liability~~, and ~~long~~-~~acting compounds pose problems of long-acting adverse effects and interactions with other drugs~~. ~~The duration of action of the synthetic cannabinoids tested using the 8-h protocol~~ have ~~varied widely~~, ~~with some producing a duration of action~~ no ~~longer than 1 h, others producing a duration~~ of ~~action between 1–2 h~~, ~~and others lasting more than 2 h~~. ~~There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound~~<br><br>~~<br>All~~ of ~~the compounds tested~~ in the ~~present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al~~.~~, 2017)~~. ~~Average horizontal activity counts~~/~~10 min as a function of time (10 min bins) and dose~~. ~~Depressant effects~~ of 1.~~33 mg/kg were observed within~~ 10 ~~min following administration~~ and ~~peak depressant effects were [https://cannabinoidsrc4f-adb~~.~~com~~/ ~~5CLADBA] observed between 0–30 min~~. ~~Duration of~~ the ~~locomotor depression increased over dose~~ from ~~30 min following 0.~~1 mg/~~kg to 2~~.~~5 h following 1 mg/k~~<br><br>~~Oxidation~~ of 4′-~~hydroxybutyl moiety in B2 led to formation~~ of 4′-~~carboxybutyl metabolite~~ (B4) ~~having a precursor ion~~ of ~~m/z 362~~, ~~which was 14 Da higher than~~ the ~~m/z for B2 (loss~~ of ~~two hydrogen atoms with addition~~ of a ~~carbonyl group~~<br><br>~~<br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose~~-~~dependent manner~~. ~~A total~~ of ~~5 mice~~ in the ~~JWH~~-~~081~~ (~~5 mg/kg, i.p.~~) ~~treated group~~ and ~~6 mice~~ in the ~~5CLADBA JWH~~-~~210~~ (~~5 mg/kg, i.p~~.) ~~treated group showed loss of traction, of which 4 and 5 showed tremor, respectively~~. ~~Memory retention was measured after~~ the ~~memory acquisition was tested as a probe trial.<br>About Powder JWH~~-~~2<br><br>While the patient's symptoms strongly suggest the inhalation~~ of ~~ADB~~-~~BUTINACA, it~~ is ~~worth considering that these symptoms could also be attributed~~ to ~~nicotine exposure~~, as the ~~symptoms partially overlap with known nicotine effect<br><br><br>Effects~~ of ~~individual doses were compared to~~ the ~~vehicle control value~~ using ~~a priori contrasts. Response~~-~~rate data were analyzed by one~~-~~way repeated~~-~~measure analysis of variance~~. ~~Percent drug-appropriate responding was shown only if~~ at ~~5CLADBA least three rats completed~~ the ~~first fixed ratio~~, ~~whereas all rats are shown for~~ the ~~response rate dat~~	+	LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden [https://cannabinoidsrc4f-adb.com/ https://cannabinoidsrc4f-adb.com/] headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl<br><br><br>Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol.<br>Fig. 2. <br>4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed and processed using TraceFinder software based on the identification criteria of mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex-mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature, and 150 µL of purified water was added. High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated in both positive and negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC-C18 analytical column (2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA).<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, https://cannabinoidsrc4f-adb.com/ liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Concentrations of 4F-MDMB-BINACA in the postmortem blood samples were 2.50 and 2.34 ng/mL, which are in line with published data. Although the lethal dose of 4F-MDMB-BINACA is unknown, its concentration in postmortem blood samples was found to range between 0.10 and 2.90 ng/mL . In SCRA-related cases in which the deceased suffered from heart disease, the SCRA concentration in the postmortem blood was less than 1 ng/mL . Concentrations of SCRAs in postmortem cases cover a wide range ; however, some reports of survival have also been published—even at relatively high blood SCRA concentrations [19, 20<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br> Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the https://cannabinoidsrc4f-adb.com/ presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom

← Nächstältere Version		Version vom 29. Juni 2026, 14:10 Uhr
Zeile 1:		Zeile 1:
−	~~LC separates~~ the ~~urine or blood sample~~ and ~~QTOF-MS provides high-resolution~~ and ~~accurate mass measurements~~ for ~~precise identification and structural elucidation of compounds~~. ~~The LC~~-~~QTOF~~-~~MS method offers a more comprehensive and sensitive approach for drug detection~~, ~~covering hundreds~~ of ~~recreational drugs~~, including ~~NPS~~. ~~Besides increasing the temperature~~ to ~~enlarge~~ the ~~drug aerolisation~~ and ~~bioavailability~~, ~~one can elevate~~ the ~~flow rate~~ of ~~air through the e~~-~~cigarette~~ and/~~or add a diluent~~ . ~~Of all e~~-~~cigarette users registered at this forum~~, 7.~~8 % vaped SCRAs . About 15 % of individuals registered at forums~~ for ~~drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong~~, ~~together with synthetic opioids~~, ~~cathinones, amphetamines~~ and ~~hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.~~<br>~~Data availabili~~<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br>~~4. Drugs~~ <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the ~~synthetic cannabinoids~~ tested in the present study ~~fully substituted~~ for ~~the discriminative stimulus effects of Δ9-THC~~. ~~Subsequently~~, ~~a one-way analysis of variance was conducted on~~ horizontal activity counts ~~for the 30-~~min ~~period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose~~ as a ~~between groups factor and~~ time ~~as a within subject factor, was conducted on horizontal activity counts/~~10 min ~~interval~~. ~~Locomotor activity in mice was tested to screen for locomotor depressant~~ effects ~~and to identify behaviorally-active dose ranges and times~~ of ~~peak effect~~. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within ~~the first~~ 10 ~~min, and maximal depression was observed between 0–30~~ min following administration~~. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial~~ depressant effects were ~~observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the~~ [https://cannabinoidsrc4f-adb.com/ ~~adb butinaca~~] ~~highest~~ dose ~~tested (~~0.5 mg/kg).<br>~~Figure 1.~~ <br>~~There is indication that at least some~~ of ~~the first~~-~~generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2~~ (~~Wiley et al., 2016~~)~~, and~~ a ~~compound from the present study, 5F-MDMB-PINACA~~, was ~~found to activate midbrain dopamine neurons, but not serotonin neurons~~ (~~Asaoka et al~~.~~, 2016)~~. ~~As previously mentioned, all~~ of ~~the compounds tested~~ in the ~~present study~~ (~~MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA~~, and ~~AMB~~-~~FUBINACA) act as agonists at CB1 receptors~~ (~~Banister et al.~~, ~~2015, 2016; Gamage et al~~.~~, 2018~~), which ~~suggests these compounds will produce Δ9-THC-like effects~~, ~~including abuse liability~~. ~~Tremors were not observed following AMB~~-~~FUBINACA during~~ the ~~drug discrimination study, but~~ the ~~maximum dose tested was only 0.1 mg/kg~~, ~~which~~ is ~~10-fold lower than the dose~~ that ~~produced tremors in~~ the ~~mic~~<br><br>~~Figure 1.~~ <br>~~Each training session lasted a maximum~~ of ~~10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior~~ to the ~~training sessions, rats received an injection of either~~ vehicle ~~or Δ9~~-~~THC and~~ were ~~subsequently placed in the behavior~~-~~testing chambers, where food (45~~-~~mg food pellets; Bio~~-~~Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection~~ appropriate ~~lever. A houselight~~ was ~~centered over the hopper close to the ceiling and was illuminated~~ only ~~when the levers were active. Each dose range included doses that were without effect to those producing~~ at least ~~50% depression compared to vehicle control. Twenty-four male Sprague-Dawley~~ rats ~~were obtained from Envigo (Houston~~, ~~TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in~~ the ~~University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin~~	+	As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narro<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br>Moreover, genetic makeup, physiological conditions (age, gender and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drug<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br><br>All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were [https://cannabinoidsrc4f-adb.com/ 5CLADBA] observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k<br><br>Oxidation of 4′-hydroxybutyl moiety in B2 led to formation of 4′-carboxybutyl metabolite (B4) having a precursor ion of m/z 362, which was 14 Da higher than the m/z for B2 (loss of two hydrogen atoms with addition of a carbonyl group<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the 5CLADBA JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.<br>About Powder JWH-2<br><br>While the patient's symptoms strongly suggest the inhalation of ADB-BUTINACA, it is worth considering that these symptoms could also be attributed to nicotine exposure, as the symptoms partially overlap with known nicotine effect<br><br><br>Effects of individual doses were compared to the vehicle control value using a priori contrasts. Response-rate data were analyzed by one-way repeated-measure analysis of variance. Percent drug-appropriate responding was shown only if at 5CLADBA least three rats completed the first fixed ratio, whereas all rats are shown for the response rate dat

← Nächstältere Version		Version vom 18. Juni 2026, 07:22 Uhr
Zeile 1:		Zeile 1:
−	~~A limitation of this case report is that we did not have a~~ urine sample ~~available for additional NPS testing. Point~~-of-~~care DOA tests using urine to screen~~ for ~~misuse~~ of ~~multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone~~. ~~THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma~~-~~hydroxybutyrate (GHB)~~ and ~~ketamine are likely to become volatile under the temperature~~ of ~~current e-cigarettes~~, ~~while crack cocaine is hard to vaporise~~. ~~A systematic review including data of 114 patients of which~~ the ~~majority was intoxicated due~~ to ~~SCRA smoking revealed that 45 % of~~ the ~~patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover~~, ~~a study conducted in~~ the ~~United Kingdom investigated components~~ of e-~~liquids in 112 samples originating from prisoners, teenagers~~ and ~~test purchases of commercially available~~ e-~~cigarettes taken between 2014 and 2021~~ . ~~This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA~~. ~~Results~~ of ~~the DOA test (including testing~~ for ~~amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone~~, opioids, ~~cannabis~~, ~~tricyclic antidepressants) were available within 30 minutes~~ and ~~were all negative. We report a case of an involuntary intoxication of~~ the ~~SCRA ADB-BUTINACA after vaping. There~~ are ~~several pitfalls in the detection of SCRA in samples taken from the patient~~.<br>Data availabili<br><br>~~Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during~~ the ~~test session~~ were ~~excluded from~~ the ~~analysis~~ of the discriminative stimulus effects of ~~that dose of test compoun<br><br><br>Test 2~~ was ~~performed everyday for 5 days after consecutive administration of the substances, including negative~~ (~~vehicle) and positive (methamphetamine) controls~~. ~~After the last administration~~, the ~~first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity~~ of a ~~substance is evaluated by animal behavioral aspects, i~~.e. ~~functional observation battery~~ (~~FOB) tests (O’Callaghan~~ et al., ~~2014~~). ~~Our results suggest that JWH~~-~~081~~ and ~~JWH~~-~~210 may [https://cannabinoidsrc4f~~-~~adb~~.~~com/ 5CLADBA] be neurotoxic substances through changing neuronal cell damages, especially in~~ the ~~core shell part~~ of ~~nucleus accumbens~~.~~<br>About Powder JWH-2~~<br><br><br>In general, the locomotor depressant and discriminative stimulus effects ~~5CLADBA~~ have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval.<br>Michael B Gatch <br>~~Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/kg.~~ Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the highest dose tested (0.5 mg/kg). ~~Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH~~<br><br>~~<br>High resolution mass spectrometry such as LC-QTOF-MS allows~~ the ~~detection~~ and ~~identification of~~ a ~~broad spectrum of recreational drugs~~, ~~including new psychoactive substances. A point~~-of-~~care drugs of abuse~~ (~~DOA~~) ~~test was initially performed on the urine of the patient~~. ~~He confirmed drinking 750 ml energy drink without any further consumption~~ of ~~food~~ and ~~using an e~~-~~cigarette from Gaziantep~~, ~~Turkey 10 seconds before the onset of his first symptoms~~. ~~He usually smokes a pack of cigarettes a day and sometimes smokes e~~-~~cigarettes~~. ~~Combined with non~~-~~specific~~, ~~transient symptoms~~, ~~clinical recognition of SCRA intoxication~~ is ~~challenging .~~<br>~~Data availability~~ <br>~~The intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the 5CLADBA presence~~ and ~~elution profiles of nicotine and ADB-BUTINACA in~~ the ~~analysed vape liquid sample~~. ~~LC-QTOF-MS Chromatograms~~ of ~~Nicotine (Top) and ADB~~-~~BUTINACA (Bottom)~~ in the ~~Vape Liquid used by the patient. The LC~~-~~QTOF~~-~~MS analysis showed that the e~~-~~liquid contained nicotine and ADB-BUTINACA~~ (~~Fig. 1~~). ~~Because~~ the ~~point-of-care DOA test is generally not able~~ to ~~detect synthetic recreational drug substances,~~ the ~~liquid of~~ the e-~~cigarette was thereafter screened using liquid chromatography-quadrupole time-of~~-~~flight mass spectrometry~~ (~~LC-QTOF-MS~~) ~~on the Waters™ Xevo G3 QTOF MS system~~. ~~After eating a light meal and drinking caffeinated sports drinks at the ER~~, ~~the nausea complaints~~ of ~~the patient were reduced~~ and the ~~patient was discharged hom~~	+	LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ adb butinaca] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic<br><br>Figure 1. <br>Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin

← Nächstältere Version		Version vom 29. Mai 2026, 02:00 Uhr
Zeile 1:		Zeile 1:
−	Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may ~~JWH~~-~~210 powder~~ be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.<br>About Powder JWH-2<br><br><br>Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients." 🌟🌟🌟🌟🌟 You can buy jwh-210 online in quantities of [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality and discreet shipping. In some areas, it is classified as a controlled substance, while in others, it may be legal for research or incense use. The legal status of jwh-210 varies by country and region.<br> Key Features and Specifications to Evaluate <br>Higher prices often reflect rigorous quality control rather than markup alone. This compound is appropriate only for authorized professionals conducting lawful research or analysis. For legitimate applications, only fully characterized, independently tested JWH-210 JWH-210 powder should be considered.<br> How to Choose Powder JWH-210 <br>When learning how to choose powder JWH-210, the most critical factor is verifying high chemical purity (≥98%) from a reputable supplier with independent lab testing. We also demonstrated that JWH-210 administration resulted in the decrease of expression levels of T-cell activator including Cd3e, Cd3g, Cd74p31, and Cd74p41, while JWH-030 increased Cd3g levels. JWH-210 (10 mg/kg, 3 days, i.p.) is more likely to have cytotoxicity and reduce lymphoid organ weight than JWH-030 of ICR mice in vivo. Users are expected to handle the compound in accordance with all applicable regulations and safety guidelines within their jurisdiction. It is important to note that JWH-210 Chemical Powder is intended strictly for research and laboratory use only. Its reputation for purity and stability has contributed to its widespread use in controlled environments where precision is paramoun<br><br><br>Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). JWH-210 powder Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br> 4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br> Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the ~~JWH-210 powder~~ highest dose tested (0.5 mg/kg).<br> ~~Figure 1.~~ <br>~~There is indication that at least some of the first~~-~~generation synthetic cannabinoids act at receptors other than cannabinoid CB1~~ and ~~CB2 (Wiley et al.~~, ~~2016~~), and ~~a compound~~ from ~~the present study~~, 5F-~~MDMB~~-~~PINACA~~, ~~was found to activate midbrain dopamine neurons~~, ~~but not serotonin neurons (Asaoka et al~~., ~~2016). As previously mentioned, all of~~ the ~~compounds tested~~ in the ~~present study~~ (~~MDMB~~-~~PINACA, MDMB~~-~~CHMICA, MDMB~~-~~FUBINACA, ADB~~-~~FUBINACA,~~ and ~~AMB~~-~~FUBINACA) act as agonists at CB1 receptors~~ (~~Banister et al~~.~~, 2015, 2016; Gamage et al~~.~~, 2018), which suggests these compounds will produce Δ9~~-~~THC~~-~~like effects, including abuse liability. Tremors were~~ not ~~observed following AMB-FUBINACA during the~~ drug ~~discrimination study~~, ~~but~~ the ~~maximum dose tested~~ was ~~only 0~~.~~1 mg/kg~~, ~~which is 10-fold lower than~~ the ~~dose that produced tremors in~~ the ~~mic~~	+	A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patient.<br>Data availabili<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may [https://cannabinoidsrc4f-adb.com/ 5CLADBA] be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.<br>About Powder JWH-2<br><br><br>In general, the locomotor depressant and discriminative stimulus effects 5CLADBA have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval.<br>Michael B Gatch <br>Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/kg. Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the highest dose tested (0.5 mg/kg). Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the 5CLADBA presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom